Is Tesla Stock Overvalued or a Buy for the Next Decade?
Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…
Sell
34
DRUG Quote, Financials, Valuation and Earnings
Last price:
$27.34
Seasonality move
:
12.19%
Day range:
$27.27 - $29.71
52-week range:
$0.93 - $79.02
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.82x
Volume:
39K
Avg. volume:
30K
1-year change:
2388.89%
Market cap:
$194.4M
Revenue:
--
EPS (TTM):
-$0.18
Earnings Data
Next earnings date for DRUG
Aug 15
2025
Most recent earnings per share
$0.01
Beat by $0.35
(Feb 13/2025)
Consensus Estimate
-$0.35
(Feb 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DRUG Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/15/2025 | Q2 | -- | -- | -- | -$0.58 | -- |
| 05/15/2025 | Q1 | -- | -- | -- | -$0.33 | -- |
| 02/13/2025 | Q4 | -- | -- | $0.01 | -$0.35 | $0.35 |
| 09/30/2024 | Q3 | -- | -- | -$0.12 | -$0.43 | $0.30 |
| 06/30/2024 | Q2 | -- | -- | $0.04 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$0.10 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.32 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.30 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.29 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.40 | -- | -- |
| 02/14/2023 | Q4 | -- | -- | -$0.48 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.77 | -- | -- |
| 08/30/2022 | Q2 | -- | -- | -$0.88 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$1.50 | -- | -- |
| 02/14/2022 | Q4 | -- | -- | -$1.63 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.97 | -- | -- |
| 08/30/2021 | Q2 | -- | -- | -$1.26 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.91 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.41 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.24 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.02 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.02 | -- | -- |
Bright Minds Biosciences Earnings Questions
-
How Much did Bright Minds Biosciences Generate in Revenue Last Quarter?
Bright Minds Biosciences reported -- worth of top line sales in its most recent quarter.
-
Did Bright Minds Biosciences Beat Earnings Last Quarter?
Bright Minds Biosciences announced earnings per share of $0.01 which represents a beat of analyst forecast a -$0.35 per share.
-
Is Bright Minds Biosciences Profitable?
Bright Minds Biosciences reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Bright Minds Biosciences EPS Next Year?
Bright Minds Biosciences's earnings are forecast to decrease from -$0.48 per share to -$0.78 per share next year representing a decrease of -237.09%.
-
When is Bright Minds Biosciences's Earnings Date?
Bright Minds Biosciences's next earnings date is August 15, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Apple Stock Undervalued or Overvalued?
For many years, Apple (NASDAQ:AAPL) was just about the perfect…
Where Will Palo Alto Networks Stock Be in 5 Years?
You know those companies that just refuse to slow down…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
68
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
58
TNXP alert for May 28
Tonix Pharmaceuticals Holding [TNXP] is up 1.57% over the past day.
Sell
37
ATS alert for May 28
ATS [ATS] is down 1.27% over the past day.
Buy
88
SMR alert for May 28
NuScale Power [SMR] is down 0.37% over the past day.
